Cellecta Awarded Phase II SBIR Grant to Finalize Development of CRISPR Screening Platform – GenomeWeb
|
Cellecta Awarded Phase II SBIR Grant to Finalize Development of CRISPR Screening Platform
GenomeWeb NEW YORK (GenomeWeb) – Cellecta announced today that it has been awarded a Phase II SBIR grant from the National Institutes of Health to complete development of a genome-wide CRISPR/Cas9 screening platform that it aims to commercialize by late … Cellecta, Inc. Receives Phase II NIH SBIR Grant to Develop Advanced CRISPR/Cas9 Genome-Wide sgRNA Library … |
